インタープロテイン List of Products and Services

"INTENDD" is an in silico technology based on a concept different from the commonly used MD calculation-based docking methods. It demonstrates high performance in drug discovery research targeting protein-protein interactions (PPI). This is our proprietary in silico drug discovery technology, capable of narrowing down from a library of ten million compounds to about 200 hit candidate compounds. [Features] ■ Maximizes the success rate of small molecule drug discovery research ■ Creation of diverse compounds with unique scaffolds ■ Accurate activity prediction at the nanomolar level ■ Hit rate of up to 20% ■ Expansion of collaborative research opportunities * You can download the English version of the catalog. * For more details, please refer to the PDF materials or feel free to contact us.

• Technology Development
• Other Protein Research
• Other Protein Research Software

Our drug discovery business is focused on controlling protein-protein interactions. We are developing our business based on two pillars: one is the research and development of small molecule drugs based on our unique "in silico molecular design method, INTENDD (Interprotein's Engine for New Drug Design)." The second is the research and development of medium-sized molecule drugs using peptide technology with a "helix-loop-helix" structural motif. [Business Overview] ■ INTENDD ■ Helix-loop-helix structural regulatory peptides *For more details, please refer to our catalog or feel free to contact us.

• Other bio-related products and services
• Peptide synthesis
• Other Protein Research